Although the biological significance of these splicing changes are not clear, these results combined with data for SRRM2 gene (see below) support the hypothesis that the aberrant RNA splicing pathway promoters cell proliferation34 in liver cancer cells. The gene discussed is SRRM2; the disease is liver cancer.